DSM-Firmenich

23 Feb 2023 

DSM and Firmenich jointly announce that they have obtained the unconditional competition clearance from the European Commission on 22 February 2023. This follows the unconditional competition clearance of China’s State Administration for Market Regulation (SAMR) received on 16 February 2023. Consequently, competition clearance has been obtained in nine out of the ten jurisdictions required to satisfy the offer condition relating to competition clearances.

The press release can be accessed here. 

23 Jan 2023 

An EGM was held on Monday 23 January 2023 at which DSM shareholders voted to approve, amongst other things, the transactions that will result in a new, dynamic creation and innovation partner in nutrition, beauty and well-being; DSM-Firmenich.

More information for DSM shareholders can be found here.

23 Jan 2023 

DSM and Firmenich confirm that the acceptance period during which DSM shareholders can tender their shares as part of the Exchange Offer that launched on 22 November 2022, has been be extended. The reason for this extension is that not all competition clearances will be obtained by 31 January 2023 although, to date, no substantive competition concerns have been identified.

The press release can be accessed here. 

22 Nov 2022

DSM and Firmenich jointly announced the launch of the exchange offer to DSM shareholders as part of the merger of equals to create DSM-Firmenich. 

More information for DSM shareholders can be found here.

The press release and associated information, including the recording of a presentation and Q&A with analysts and investors, can be accessed here.

28 Jun 2022

Pursuant to Section 7, paragraph 1 sub a of the Netherlands Decree on Public Takeover Bids (Besluit openbare biedingen Wft), which requires a public announcement containing a status update on an intended public offer within four weeks after its initial public announcement, DSM and Firmenich confirm that they are making good progress on the preparations for the Offer.

The press release can be accessed here. 

13 Jun 2022

DSM and Firmenich hosted a joint Capital Markets Day for institutional investors and equity analysts, to provide a deeper understanding of Firmenich’s businesses and to present DSM-Firmenich, outlining its key value drivers, demonstrating how the complementary nature of the companies can enable enhanced innovation and co-creation with their customers, and through this, increase returns and deliver long-term sustainable growth and shareholder value.

Held at the Palais Brongniart, the historical Paris stock exchange, the recording of the presentations and the Q&A session is available to be watched back here.

13 Jun 2022

DSM and Firmenich jointly announced the future leadership team for DSM-Firmenich. The Executive Committee will have a balanced team of talented individuals drawn from both DSM and Firmenich and representing the diversity, skillset, and ambitions of the combined company.

The press release can be accessed here. 

31 May 2022

DSM and Firmenich announced an intention to merge to become the leading creation and innovation partner in nutrition, beauty and well-being. The combination will bring together Firmenich’s unique leading Perfumery and Taste businesses, its world-class science platforms and associated co-creation capabilities with DSM’s outstanding Health and Nutrition portfolio and renowned scientific expertise.

The press release can be accessed here.